Ignite Creation Date:
2025-12-24 @ 5:21 PM
Ignite Modification Date:
2026-01-20 @ 2:45 AM
Study NCT ID:
NCT00193050
Status:
COMPLETED
Last Update Posted:
2021-10-26
First Post:
2005-09-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer
Sponsor:
Organization: